DUBLIN--(BUSINESS WIRE)--The "Tuberous Sclerosis Complex (TSC) - Market Insights, Epidemiology and Market Forecast-2027" drug pipelines has been added to ResearchAndMarkets.com's offering.
The market of Tuberous Sclerosis Complex (TSC) in 7MM was found to be USD 372 million in 2016.
Tuberous Sclerosis Complex (TSC) - Market Insights, Epidemiology and Market Forecast-2027 report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of TSC in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom), and Japan.
The Report provides the current treatment practices, emerging drugs having the potential to get launched in the forecast period, market share of the individual therapies, current and forecasted market size of Tuberous Sclerosis Complex (TSC) from 2016 to 2027 segmented by seven major markets. The Report also covers current treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assess underlying potential of the market.
Key Topics Covered:
1. Key Insights
2. Tuberous Sclerosis Complex (TSC) Market Overview at a Glance
3. Disease Overview: Tuberous Sclerosis Complex (TSC)
4. Epidemiology and Patient Population
5. 7MM Total Prevalent Patient Population of Tuberous Sclerosis Complex
6. Country Wise-Epidemiology of Tuberous Sclerosis Complex
7. Current Treatment Practices
8. Unmet Needs
9. Marketed drugs
10. Emerging Therapies
11. Tuberous Sclerosis Complex: 7 Major Market Analysis
12. Market Outlook by Country
13. The United States: Market Outlook
14. EU-5 Countries: Market Outlook
15. Market Drivers
16. Market Barriers
- Novartis Pharmaceuticals
- Nobelpharma Co., Ltd
- GW Pharmaceuticals
- Takeda Pharmaceutical Company Limited
For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/35fksq/tuberous?w=4